SP1 and pancreatic neoplasm: Preliminary work has shown that NFATc2 interacts with other transcriptional partners, such as the oncogenic protein Sp1 in pancreatic cancer, and that carcinogenic effects are caused by the interaction of NFATc2 and Sp1 [16].